Modified DNA backbone enables success of existing and novel oligonucleotide therapeutics
2014-11-13
(Press-News.org) New Rochelle, NY, November 13, 2014--The two U.S. FDA approved oligonucleotide-based drugs on the market both have a modified chemical backbone made of phosphorothioates. The therapeutic advantages of the phosphorothioate group and the new types of gene expression-regulation oligonucleotide drugs that it is enabling are detailed in a Review article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers. The article is available free on the Nucleic Acid Therapeutics website until December 13, 2014.
In the article "Phosphorothioates, Essential Components of Therapeutic Oligonucleotides," Fritz Eckstein, Max-Planck-Institut für Experimentelle Medizin, Göttingen, Germany, describes how the chemical and biochemical properties of this significant nucleic acid modification have made DNA suitable for use as therapeutic agents. Initial applications focused on cleaving the mRNA product of genes to block protein production. Dr. Eckstein explores novel applications including microRNA and long non-coding RNA targets and the use of decoy oligonucleotides.
"We will advance the field of nucleic acid therapeutics by looking to key opinion leaders to educate and initiate the experienced and newcomers alike. In this review, Dr. Eckstein has produced a tour de force concerning the therapeutic application of phosphorothioates," says Executive Editor Graham C. Parker, PhD, The Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine, Children's Hospital of Michigan, Detroit, MI.
INFORMATION:
Nucleic Acid Therapeutics is under the editorial leadership of Co-Editors-in-Chief Bruce A. Sullenger, PhD, Duke Translational Research Institute, Duke University Medical Center, Durham, NC, and C.A. Stein, MD, PhD, City of Hope National Medical Center, Duarte, CA; and Executive Editor Graham C. Parker, PhD.
About the Journal
Nucleic Acid Therapeutics is an authoritative, peer-reviewed journal published bimonthly in print and online that focuses on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. Nucleic Acid Therapeutics is the official journal of the Oligonucleotide Therapeutics Society. Complete tables of content and a sample issue may be viewed on the Nucleic Acid Therapeutics website.
About the Society
The Oligonucleotide Therapeutics Society is an open, non-profit forum to foster academia- and industry-based research and development of oligonucleotide therapeutics. The society brings together the expertise from different angles of oligonucleotide research to create synergies and to bring the field of oligonucleotides to its full therapeutic potential.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Human Gene Therapy, Assay and Drug Development Technologies, Applied In Vitro Toxicology, and DNA and Cell Biology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2014-11-13
WEST LAFAYETTE, Ind. - Researchers from Purdue and Colorado State universities have discovered that the fungus responsible for thousand cankers disease, a lethal affliction of walnut trees and related species, has a rich genetic diversity that may make the disease more difficult to control.
Adjunct assistant professor of forestry Keith Woeste and fellow researchers analyzed the genes of 209 samples of Geosmithia morbida from 17 regions of the U.S. to determine the genetic diversity of the fungus, its possible origin and how it spread throughout the West and to parts of ...
2014-11-13
Anesthesia, long considered a blessing to patients and surgeons, has been a mystery for much of its 160-plus-year history in the operating room.
No one could figure out how these drugs interact with the brain to block pain and induce a coma-like, memory-free state. The debate has divided the anesthesia research community into two camps: one that believes anesthetics primarily act on the cell membrane (the lipid bilayer) of nerve cells, perhaps altering it to the point that embedded proteins cannot function normally. The other says the membrane proteins themselves are ...
2014-11-13
For the first time in history, a spacecraft has landed on a comet. The momentous event represents the culmination of 35 years of research on comets by Prof. Akiva Bar-Nun of Tel Aviv University's Department of Geosciences and other scientists working for the European Space Agency.
At 08:35 GMT on Wednesday, November 12, the European Space Agency's Rosetta satellite released its lander Philae towards Comet 67P/Churyumov-Gerasimenko, a large mass of ice and dust some 316 million miles from Earth. The descent took approximately seven hours, with a signal confirming touchdown ...
2014-11-13
West Lafayette, Ind. (November 13, 2014): Scientists with the U.S. Forest Service and Colorado State University examined a fungus native to North America, the native beetle that carries it, and their host tree and found something surprising: Geosmithia morbida and the walnut twig beetle co-evolved and, while the beetle/fungus complex was once the equivalent of a hang nail for a black walnut tree, it has become lethal.
Research published today in the journal PLOS ONE by U.S. Forest Service scientist Keith Woeste, Colorado State University scientists Marcelo M. Zerillo ...
2014-11-13
This news release is available in French. Montreal November 13, 2014 - Is it possible to change the amount of information the brain can store? Maybe, according to a new international study led by the Research Institute of the McGill University Health Centre (RI-MUHC). Their research has identified a molecule that puts a brake on brain processing and when removed, brain function and memory recall is improved. Published in the latest issue of Cell Reports, the study has implications for neurodevelopmental and neurodegenerative diseases, such as autism spectral disorders ...
2014-11-13
TORONTO, ON (13 November 2014) Astronomers from the University of Toronto and the University of Arizona have provided the first direct evidence that an intergalactic "wind" is stripping galaxies of star-forming gas as they fall into clusters of galaxies. The observations help explain why galaxies found in clusters are known to have relatively little gas and less star formation when compared to non-cluster or "field" galaxies.
Astronomers have theorized that as a field galaxy falls into a cluster of galaxies, it encounters the cloud of hot gas at the centre of the cluster. ...
2014-11-13
Some plants form into new species with a little help from their friends, according to Cornell University research published Oct. 27 in the Proceedings of the National Academy of Sciences.
The study finds that when plants develop mutually beneficial relationships with animals, mainly insects, those plant families become more diverse by evolving into more species over time.
The researchers conducted a global analysis of all vascular plant families, more than 100 of which have evolved sugary nectar-secreting glands that attract and feed protective animals, such as ants. ...
2014-11-13
Who would have thought a Sesame Street video starring the Cookie Monster, of all characters, could teach preschoolers self-control?
But that's exactly what Deborah Linebarger, an associate professor in Teacher and Learning at the University of Iowa, found when she studied a group of preschoolers who repeatedly watched videos of Cookie Monster practicing ways to control his desire to eat a bowl of chocolate chip cookies.
"Me want it," Cookie Monster sings in one video, "but me wait."
In fact, preschoolers who viewed the Cookie Monster video were able to wait four ...
2014-11-13
In a potential breakthrough against ovarian cancer, University of Guelph researchers have discovered how to both shrink tumours and improve drug delivery, allowing for lower doses of chemotherapy and reducing side effects.
Their research appears today in the FASEB Journal, one of the world's top biology publications.
"We hope that this study will lead to novel treatment approaches for women diagnosed with late-stage ovarian cancer," said Jim Petrik, a Guelph biomedical sciences professor. He worked on the study with Guelph graduate student Samantha Russell and cancer ...
2014-11-13
LAWRENCE -- Like hedonistic rock stars that live by the "better to burn out than to fade away" credo, certain galaxies flame out in a blaze of glory. Astronomers have struggled to grasp why these young "starburst" galaxies -- ones that are very rapidly forming new stars from cold molecular hydrogen gas up to 100 times faster than our own Milky Way -- would shut down their prodigious star formation to join a category scientists call "red and dead."
Starburst galaxies typically result from the merger or close encounter of two separate galaxies. Previous research had revealed ...
LAST 30 PRESS RELEASES:
[Press-News.org] Modified DNA backbone enables success of existing and novel oligonucleotide therapeutics
